ZURA - Zura Bio Limited Class A Ordinary Shares

ZURA - Zura Bio Limited Class A Ordinary Shares

https://zurabio.com

Recent News

Powered by Alpha Vantage

Down -35.58% in 4 Weeks, Here's Why You Should You Buy the Dip in Zura Bio Limited ( ZURA )

Zacks Commentary • 7 months, 3 weeks ago • score: 0.20

Zura Bio Limited (ZURA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near ...

Zura Bio Limited ( ZURA ) Upgraded to Buy: Here's What You Should Know

Zacks Commentary • 1 year, 4 months ago • score: 0.18

Zura Bio Limited (ZURA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday - XIAO-I ( NASDAQ:AIXI ) , Alvotech ( NASDAQ:ALVO )

Benzinga • 2 years, 2 months ago • score: -0.59

BioXcel Therapeutics, Inc. BTAI shares dropped 62.2% to $6.68 after the company released topline results from TRANQUILITY II Phase 3 trial of BXCL501 for acute treatment of Alzheimer's Disease-related agitation. Liquidia Corporation LQDA fell 15% to $8.42.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$5.07

52W Low

$0.97

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-0.02

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-2.34

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

1.14

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

27.75%

Institutions (25–75% balanced)

51.24%

Shares Outstanding

65,018,000

Float

37,881,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-0.74

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.44%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—